← Back to Search

KIOS Informational App evaluation for Opioid Use Disorder (KIOS-I Trial)

N/A
Waitlist Available
Led By Jennifer Potter, Ph.D.
Research Sponsored by Biomedical Development Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2.
Awards & highlights

KIOS-I Trial Summary

This trial tests a smartphone app for opioid use disorder to provide drug info to people in recovery. It will confirm design and specs before a larger clinical trial.

Who is the study for?
This trial is for adults over 18 who are currently in an opioid treatment program and have been stable in their outpatient treatment for at least 4 weeks. Participants must be able to use the app on a smartphone or tablet. It's not for those unwilling to follow study rules, incarcerated individuals, pregnant women, or people with psychiatric or medical conditions that would hinder app usage.Check my eligibility
What is being tested?
The trial is testing the KIOS Informational App designed to support self-management of opioid use disorder. The focus is on assessing how well the app works technically and whether it meets design specifications before a larger clinical trial evaluates its impact on health outcomes.See study design
What are the potential side effects?
Since this study tests an informational app rather than a drug or medical procedure, traditional physical side effects are not expected. However, users may experience stress or discomfort from engaging with content about opioid recovery.

KIOS-I Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2.
This trial's timeline: 3 weeks for screening, Varies for treatment, and a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Usability Score
Secondary outcome measures
User Satisfaction

KIOS-I Trial Design

1Treatment groups
Experimental Treatment
Group I: KIOS Informational App evaluationExperimental Treatment1 Intervention
Study participants will use the app at least three times per week. The app will contain a user interface that includes a login page, true/false questions for the user to answer, verified public domain educational information about drug and alcohol use, Likert-type questions regarding the information presented, and a closing "Thank You" screen.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioOTHER
452 Previous Clinical Trials
91,389 Total Patients Enrolled
Biomedical Development CorporationLead Sponsor
13 Previous Clinical Trials
858 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,568 Total Patients Enrolled

Media Library

Opioid Use Disorder Clinical Trial 2023: KIOS Informational App evaluation Highlights & Side Effects. Trial Name: NCT05859035 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being admitted to this research project?

"Affirmative. According to clinicaltrials.gov, this research trial is actively seeking participants with the first post on June 29th 2023 and a recent update on July 11th 2023. The team aims to recruit 25 people from 1 clinic."

Answered by AI

Is this clinical experiment presently enlisting participants?

"Correct. According to information available on clinicaltrials.gov, this medical study is still recruiting participants. It was initially posted on June 29th 2023 and updated just recently on July 11th 2023; 25 patients are being sought from 1 site."

Answered by AI
~14 spots leftby Apr 2025